CREKA peptide (acetate)
CREKA peptide acetate is a short peptide sequence, belonging to self-assembling peptides (SAPs), which can self-assemble into functional nanostructures, typically nanofibers, under physiological conditions. CREKA peptide acetate can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity[1].
Product Specifications
UNSPSC
12352209
Target
Biochemical Assay Reagents
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Purity
98.07
Smiles
CC(O)=O.O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)[C@H](CS)N
Molecular Formula
C25H47N9O10S
Molecular Weight
665.76
References & Citations
[1]Zhang N, et al. Recent advances of CREKA peptide-based nanoplatforms in biomedical applications. J Nanobiotechnology. 2023 Mar 3;21 (1) :77.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal TRAIL R1/TNFRSF10A Antibody (32A1380) [DyLight 550]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Mouse Monoclonal TRAIL R1/TNFRSF10A Antibody (32A1380) [DyLight 550]
CAND1 (Cullin-Associated and Neddylation-dissociated 1, DKFZp434M1414, FLJ10114, FLJ10929, FLJ38691, FLJ90441, KIAA0829, TIP120, TIP120A) (Biotin)
CAND1 (Cullin-Associated and Neddylation-dissociated 1, DKFZp434M1414, FLJ10114, FLJ10929, FLJ38691, FLJ90441, KIAA0829, TIP120, TIP120A) (Biotin)
